PerkinElmer Acquired Microarray Company Spectral Genomics

Boston, MA –PerkinElmer has acquired the assets of Spectral Genomics for an undisclosed sum. Spectral Genomics provides microarrays and software for the identification of chromosomal abnormalities related to the study of cancer and pre-and post-natal genetic disorders. “Spectral Genomics’ innovative technologies are highly complementary to our current molecular medicine and genetic screening offerings,” said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences.

< | >